Gilead’s Acquisition of XinThera

Wilson Sonsini Goodrich & Rosati advised XinThera on the transaction.Gilead Sciences announced the acquisition of San Diego-based XinThera, a privately held biotech company. The acquisition will…

Standard 1 Year Membership Required

You must be a Standard 1 Year member to access this content.

Join Now

Already a member? Log in here
Martina Bellini

Author: Martina Bellini

Standard 1 Year Membership Required

You must be a Standard 1 Year member to access this content.

Join Now

Already a member? Log in here